Integra LifeSciences Holdings Corporation
IART
$9.55
-$0.02-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.70M | -5.40M | -484.07M | -25.29M | 19.44M |
| Total Depreciation and Amortization | 38.43M | 38.52M | 37.69M | 37.19M | 44.69M |
| Total Amortization of Deferred Charges | 1.02M | 1.32M | 1.89M | 1.39M | 1.40M |
| Total Other Non-Cash Items | -10.58M | -17.83M | 471.44M | 117.00K | -2.80M |
| Change in Net Operating Assets | -15.35M | 24.30M | -18.03M | -24.65M | -11.99M |
| Cash from Operations | 11.82M | 40.91M | 8.92M | -11.26M | 50.74M |
| Capital Expenditure | -17.21M | -15.16M | -20.15M | -28.92M | -29.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 4.18M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.69M | -432.00K | -1.50M | -7.00M | 21.17M |
| Cash from Investing | -34.91M | -15.59M | -21.65M | -35.92M | -4.25M |
| Total Debt Issued | 49.70M | 603.70M | 12.90M | 54.40M | 35.40M |
| Total Debt Repaid | -25.09M | -613.67M | -15.89M | -15.24M | -39.94M |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 957.00K | 0.00 |
| Repurchase of Common Stock | -137.00K | -199.00K | -446.00K | -2.14M | -2.61M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -134.00K | -75.00K | -17.71M | -2.60M | 0.00 |
| Cash from Financing | 24.34M | -10.25M | -21.14M | 35.38M | -7.15M |
| Foreign Exchange rate Adjustments | 1.61M | -801.00K | 12.68M | 4.53M | -8.12M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.86M | 14.27M | -21.19M | -7.27M | 31.22M |